Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1980-10-27
pubmed:abstractText
Two independent surveys have been conducted to determine the prevalent bacterial species and beta-lactamase types present in clinical populations of gram-negative, ampicillin-resistant isolates. A total of 208 isolates (112 from Nottingham Hospital and 96 from Charing Cross Hospital), all of which had been collected from out-patients suffering from urinary tract infections, were investigated. The incidence of ampicillin-resistant isolates (minimum inhibitory concentrations, 8 micrograms/ml) was 24.1% and 18.8% within the Nottingham and Charing Cross samples, respectively. The surveys gave similar results within the ampicillin-resistant samples. Escherichia coli was the prevalent bacterial species (52.9%), followed by Klebseilla pneumoniae (30.3%). The majority of isolates, at least 54.8% and possibly as high as 74.5%, owed their principal beta-lactamase activity to enzymes mediated by R-plasmids. The most prevalent beta-lactamases were TEM-1 (53.3%), SHV-1 (30.9%), and OXA-1 (11.5%). Positive associations were found between E. coli and TEM-1 or OXA-1 and between K. pneumoniae and SHV-1.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-1091625, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-1107329, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-329756, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-378931, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-385575, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-392225, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4212391, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4528040, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4553144, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4566421, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4569692, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4587613, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4604884, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4605004, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4689215, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-4942447, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-5326330, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-5328167, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-6061177, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-783110, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-807678, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-819625, http://linkedlifedata.com/resource/pubmed/commentcorrection/6996612-883818
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
929-36
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections.
pubmed:publicationType
Journal Article